Cargando…

Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013

During 2012, global detection of a new norovirus (NoV) strain, GII.4 Sydney, raised concerns about its potential effect in the United States. We analyzed data from NoV outbreaks in 5 states and emergency department visits for gastrointestinal illness in 1 state during the 2012–13 season and compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Leshem, Eyal, Wikswo, Mary, Barclay, Leslie, Brandt, Eric, Storm, William, Salehi, Ellen, DeSalvo, Traci, Davis, Tim, Saupe, Amy, Dobbins, Ginette, Booth, Hillary A., Biggs, Christianne, Garman, Katie, Woron, Amy M., Parashar, Umesh D., Vinjé, Jan, Hall, Aron J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739516/
https://www.ncbi.nlm.nih.gov/pubmed/23886013
http://dx.doi.org/10.3201/eid1908.130458
_version_ 1782476933473239040
author Leshem, Eyal
Wikswo, Mary
Barclay, Leslie
Brandt, Eric
Storm, William
Salehi, Ellen
DeSalvo, Traci
Davis, Tim
Saupe, Amy
Dobbins, Ginette
Booth, Hillary A.
Biggs, Christianne
Garman, Katie
Woron, Amy M.
Parashar, Umesh D.
Vinjé, Jan
Hall, Aron J.
author_facet Leshem, Eyal
Wikswo, Mary
Barclay, Leslie
Brandt, Eric
Storm, William
Salehi, Ellen
DeSalvo, Traci
Davis, Tim
Saupe, Amy
Dobbins, Ginette
Booth, Hillary A.
Biggs, Christianne
Garman, Katie
Woron, Amy M.
Parashar, Umesh D.
Vinjé, Jan
Hall, Aron J.
author_sort Leshem, Eyal
collection PubMed
description During 2012, global detection of a new norovirus (NoV) strain, GII.4 Sydney, raised concerns about its potential effect in the United States. We analyzed data from NoV outbreaks in 5 states and emergency department visits for gastrointestinal illness in 1 state during the 2012–13 season and compared the data with those of previous seasons. During August 2012–April 2013, a total of 637 NoV outbreaks were reported compared with 536 and 432 in 2011–2012 and 2010–2011 during the same period. The proportion of outbreaks attributed to GII.4 Sydney increased from 8% in September 2012 to 82% in March 2013. The increase in emergency department visits for gastrointestinal illness during the 2012–13 season was similar to that of previous seasons. GII.4 Sydney has become the predominant US NoV outbreak strain during the 2012–13 season, but its emergence did not cause outbreak activity to substantially increase from that of previous seasons.
format Online
Article
Text
id pubmed-3739516
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-37395162013-08-14 Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013 Leshem, Eyal Wikswo, Mary Barclay, Leslie Brandt, Eric Storm, William Salehi, Ellen DeSalvo, Traci Davis, Tim Saupe, Amy Dobbins, Ginette Booth, Hillary A. Biggs, Christianne Garman, Katie Woron, Amy M. Parashar, Umesh D. Vinjé, Jan Hall, Aron J. Emerg Infect Dis Research During 2012, global detection of a new norovirus (NoV) strain, GII.4 Sydney, raised concerns about its potential effect in the United States. We analyzed data from NoV outbreaks in 5 states and emergency department visits for gastrointestinal illness in 1 state during the 2012–13 season and compared the data with those of previous seasons. During August 2012–April 2013, a total of 637 NoV outbreaks were reported compared with 536 and 432 in 2011–2012 and 2010–2011 during the same period. The proportion of outbreaks attributed to GII.4 Sydney increased from 8% in September 2012 to 82% in March 2013. The increase in emergency department visits for gastrointestinal illness during the 2012–13 season was similar to that of previous seasons. GII.4 Sydney has become the predominant US NoV outbreak strain during the 2012–13 season, but its emergence did not cause outbreak activity to substantially increase from that of previous seasons. Centers for Disease Control and Prevention 2013-08 /pmc/articles/PMC3739516/ /pubmed/23886013 http://dx.doi.org/10.3201/eid1908.130458 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Leshem, Eyal
Wikswo, Mary
Barclay, Leslie
Brandt, Eric
Storm, William
Salehi, Ellen
DeSalvo, Traci
Davis, Tim
Saupe, Amy
Dobbins, Ginette
Booth, Hillary A.
Biggs, Christianne
Garman, Katie
Woron, Amy M.
Parashar, Umesh D.
Vinjé, Jan
Hall, Aron J.
Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013
title Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013
title_full Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013
title_fullStr Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013
title_full_unstemmed Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013
title_short Effects and Clinical Significance of GII.4 Sydney Norovirus, United States, 2012–2013
title_sort effects and clinical significance of gii.4 sydney norovirus, united states, 2012–2013
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739516/
https://www.ncbi.nlm.nih.gov/pubmed/23886013
http://dx.doi.org/10.3201/eid1908.130458
work_keys_str_mv AT leshemeyal effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT wikswomary effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT barclayleslie effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT brandteric effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT stormwilliam effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT salehiellen effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT desalvotraci effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT davistim effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT saupeamy effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT dobbinsginette effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT boothhillarya effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT biggschristianne effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT garmankatie effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT woronamym effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT parasharumeshd effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT vinjejan effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013
AT hallaronj effectsandclinicalsignificanceofgii4sydneynorovirusunitedstates20122013